SOUTH SAN FRANCISCO, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address ...
SOUTH SAN FRANCISCO, Calif., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on improving patient outcomes ...
ALG is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of ALG shares has increased $0.92 since the market last closed. This is a 0.57% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results